Stephen Walimbwa

801 total citations
12 papers, 230 citations indexed

About

Stephen Walimbwa is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Stephen Walimbwa has authored 12 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Virology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stephen Walimbwa's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and HIV/AIDS Research and Interventions (4 papers). Stephen Walimbwa is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and HIV/AIDS Research and Interventions (4 papers). Stephen Walimbwa collaborates with scholars based in Uganda, United Kingdom and United States. Stephen Walimbwa's co-authors include Mohammed Lamorde, Catriona Waitt, Giovanni Di Perri, Valeria Avataneo, Alessandra Manca, Antonio D’Avolio, Jessica Cusato, Amedeo De Nicolò, Andrew Kambugu and Joseph Musaazi and has published in prestigious journals such as New England Journal of Medicine, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Stephen Walimbwa

11 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Walimbwa Uganda	6	156	77	40	33	24	12	230
Katya Govender South Africa	10	110 0.7×	50 0.6×	36 0.9×	62 1.9×	19 0.8×	16	235
Rita de Cássia Elias Estrela Brazil	10	159 1.0×	53 0.7×	41 1.0×	41 1.2×	24 1.0×	20	283
Naoya Okumura Japan	9	159 1.0×	76 1.0×	31 0.8×	45 1.4×	14 0.6×	17	331
Marga Teulen Netherlands	8	179 1.1×	30 0.4×	70 1.8×	78 2.4×	11 0.5×	12	290
L. Trentini Italy	11	257 1.6×	137 1.8×	30 0.8×	78 2.4×	9 0.4×	25	354
G Tossini Italy	7	141 0.9×	70 0.9×	24 0.6×	109 3.3×	21 0.9×	11	320
Yoninah Cramer United States	9	211 1.4×	98 1.3×	27 0.7×	130 3.9×	6 0.3×	17	345
Diana F. Clarke United States	9	156 1.0×	65 0.8×	41 1.0×	57 1.7×	4 0.2×	22	274
Simbarashe Zvada South Africa	9	169 1.1×	39 0.5×	68 1.7×	72 2.2×	4 0.2×	12	276
Justin Chiong United Kingdom	7	73 0.5×	42 0.5×	14 0.3×	21 0.6×	4 0.2×	11	191

Countries citing papers authored by Stephen Walimbwa

Since Specialization

Citations

This map shows the geographic impact of Stephen Walimbwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Walimbwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Walimbwa more than expected).

Fields of papers citing papers by Stephen Walimbwa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Walimbwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Walimbwa. The network helps show where Stephen Walimbwa may publish in the future.

Co-authorship network of co-authors of Stephen Walimbwa

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Walimbwa. A scholar is included among the top collaborators of Stephen Walimbwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Walimbwa. Stephen Walimbwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Kuchař, Milan, Leona Rašková Kafková, Jozef Škarda, et al.. (2024). Human IL-22 receptor-targeted small protein antagonist suppress murine DSS-induced colitis. Cell Communication and Signaling. 22(1). 469–469. 2 indexed citations

Walimbwa, Stephen, Petr Malý, Leona Rašková Kafková, & Milan Raška. (2024). Beyond glycan barriers: non-cognate ligands and protein mimicry approaches to elicit broadly neutralizing antibodies for HIV-1. Journal of Biomedical Science. 31(1). 83–83.

Chappell, Catherine A., Pauline Byakika‐Kibwika, Julian Kaboggoza, et al.. (2022). Pharmacokinetics of levonorgestrel and etonogestrel contraceptive implants over 48 weeks with rilpivirine- or darunavir-based antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 77(11). 3144–3152. 6 indexed citations

Walimbwa, Stephen, Goonaseelan Pillai, Saye Khoo, et al.. (2021). Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine. Journal of Antimicrobial Chemotherapy. 76(5). 1269–1272. 5 indexed citations

Walimbwa, Stephen, Julian Kaboggoza, Catriona Waitt, et al.. (2021). An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR). Trials. 22(1). 831–831. 2 indexed citations

Paton, Nicholas I., Joseph Musaazi, Cissy Kityo, et al.. (2021). Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV. New England Journal of Medicine. 385(4). 330–341. 91 indexed citations

Siu, Godfrey, Henry W. Nabeta, Stephen Walimbwa, et al.. (2020). “You would not be in a hurry to go back home”: patients’ willingness to participate in HIV/AIDS clinical trials at a clinical and research facility in Kampala, Uganda. BMC Medical Ethics. 21(1). 77–77. 2 indexed citations

Avataneo, Valeria, Amedeo De Nicolò, Jessica Cusato, et al.. (2020). Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. Journal of Antimicrobial Chemotherapy. 75(7). 1772–1777. 76 indexed citations

Orrell, Catherine, Kenneth Kintu, Alieu Amara, et al.. (2018). DolPHIN-1: Randomised controlled trial of dolutegravir (DTG)- versus efavirenz (EFV)-based therapy in mothers initiating antiretroviral treatment in late pregnancy. Spiral (Imperial College London). 2 indexed citations

10.

Walimbwa, Stephen, Mohammed Lamorde, Catriona Waitt, et al.. (2018). Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine. Antimicrobial Agents and Chemotherapy. 63(2). 17 indexed citations

11.

Nakiyingi, Lydia, et al.. (2017). Possible misdiagnosis of HIV associated lymphoma as tuberculosis among patients attending Uganda Cancer Institute. AIDS Research and Therapy. 14(1). 13–13. 19 indexed citations

12.

Lamorde, Mohammed, Stephen Walimbwa, Pauline Byakika‐Kibwika, et al.. (2015). Steady-state pharmacokinetics of rilpivirine under different meal conditions in HIV-1-infected Ugandan adults. Journal of Antimicrobial Chemotherapy. 70(5). 1482–1486. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact